Tenax Therapeutics
Price & Volume
Stats
See more52W Range | $5.78-$19.40 |
Market Cap | $488.3M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.40 |
News
See moreYahoo Finance • 7 days ago
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance • last month
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026
Yahoo Finance • 5 months ago
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
About
CEO | Mr. Christopher T. Giordano |
Address | 101 Glen Lennox Drive, Chapel Hill, NC, United States, 27517 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |